← All Startups

Volastra Therapeutics

Series A
Cancer therapies targeting chromosomal instability
Location
New York, NY
Website
volastratx.com
LinkedIn
View profile
Founders
Lewis Cantley, PhD ’75
Olivier Elemento, Professor
BiotechnologyLife ScienceMedical
Similar Startups
OpenEvidence
Organizing the world’s medical knowledge
Zachary Ziegler ’17
Series E
Tiny Health
Microbiome tests for mother/baby's gut health insights
Cheryl Yeoh ’06
Series B
Soufflé Therapeutics
Cell-specific therapeutics
Susan Langer Denner ’13, Robert Langer ’70
Series B
Biotia
Infectious disease diagnostics
Niamh O’Hara, PostDoc ’18
Seed
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11
Moderna
mRNA vaccines
Robert Langer ’70

Volastra Therapeutics is a Cornell-founded startup based in New York, NY, founded by Lewis Cantley, PhD ’75 and Olivier Elemento, Professor.